Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cardinal/Bindley Aims To Pass McKesson In Revenues Without FTC Scrutiny

This article was originally published in The Tan Sheet

Executive Summary

Cardinal's proposed acquisition of Bindley Western is an attempt to complete a deal large enough to pass McKesson as the top drug wholesaler but small enough to avoid scrutiny by the Federal Trade Commission.

You may also be interested in...



AmeriSource Expects Post-Merger Market Share Of 33% To Pass FTC Review

AmeriSource and Bergen Brunswig predict the Federal Trade Commission will accept their combined 33% market share in the drug wholesaling sector without initiating an antitrust challenge.

AmeriSource Expects Post-Merger Market Share Of 33% To Pass FTC Review

AmeriSource and Bergen Brunswig predict the Federal Trade Commission will accept their combined 33% market share in the drug wholesaling sector without initiating an antitrust challenge.

AmeriSource Expects Post-Merger Market Share Of 33% To Pass FTC Review

AmeriSource and Bergen Brunswig predict the Federal Trade Commission will accept their combined 33% market share in the drug wholesaling sector without initiating an antitrust challenge.

Topics

UsernamePublicRestriction

Register

PS091977

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel